The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience DOI Creative Commons
Dafna Sara Rubin-Kahana, Jean‐François Crépault, Justin Matheson

et al.

Frontiers in Psychiatry, Journal Year: 2022, Volume and Issue: 13

Published: Sept. 23, 2022

Cannabis legalization for non-medical purposes (subsequently referred to as “cannabis legalization” or “legalization”) took place in Canada October 2018. One of the federal government's stated goals with cannabis was protect Canadian youth from cannabis-related harms. The main objective this narrative review is describe impact on youth. To that end, we discuss regulation market, outline changes epidemiology and parameters use (modes use, potency cannabis) among youth, prevention education initiatives related cannabis. model differs other jurisdictions legalized recreational especially regard a higher degree government market. Another difference development endorsement lower-risk guidelines educate public health professionals. results available cover only 3 years post-legalization. brought an apparent increase older than 25. However, are mixed, majority studies showing no pronounced increase. Notably, trend decrease adolescents' seen pre-legalization may have reversed. Emerging evidence also suggests hospitalizations emergency department visits increased due legalization. Data about age initiation, influence sex gender, race/ethnicity limited, suggesting initiation slightly increased. So far, there limited data Further long-term monitoring research assess effects

Language: Английский

Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults DOI
Jeremy Mennis, Thomas P. McKeon, Gerald J. Stahler

et al.

Addictive Behaviors, Journal Year: 2022, Volume and Issue: 138, P. 107552 - 107552

Published: Nov. 17, 2022

Language: Английский

Citations

62
Prevalence of Adolescent Cannabis Vaping DOI
Carmen Lim, Tianze Sun, Janni Leung

et al.

JAMA Pediatrics, Journal Year: 2021, Volume and Issue: 176(1), P. 42 - 42

Published: Oct. 25, 2021

Vaping products were initially designed to deliver nicotine as a tobacco cigarette substitute (eg, electronic cigarettes) but are now frequently used psychoactive substances, such cannabis and its derivatives. Large, nationally representative surveys, Monitoring the Future, found that approximately 1 in 3 grade-12 students vaped 2018 alone.To summarize findings of epidemiological studies reported global prevalence vaping adolescents by survey year school grades.PubMed, PsycINFO, Scopus, Web Science searched systematically on August 19, 2020, for published globally between January 1, 2003, 2020.Publications general population included.Study characteristics estimates extracted from each article. Random-effects meta-analysis based DerSimonian Laird method meta-regression performed lifetime, 12-month, 30-day estimates. Meta-regression was also conducted using grades moderators.Prevalence vaping.Seventeen met eligibility criteria (n = 198 845 adolescents). Although no restrictions imposed study location, all 17 US Canada. Across grades, pooled increased lifetime use (6.1% 2013-2016 13.6% 2019-2020), past 12 months (7.2% 2017-2018 13.2% 30 days (1.6% 8.4% 2019-2020). Heterogeneity across large. The limited evidence similar designs suggested adolescents' preference other than dried herbs, which usually contain higher Δ9-tetrahydrocannabinol levels, may have shifted over time.The this suggest has among Canada more effective preventive response measures required.PROSPERO Identifier: CRD42020219644.

Language: Английский

Citations

59
Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis DOI
Tessa Robinson, Muhammad Usman Ali, Bethany Easterbrook

et al.

Drug and Alcohol Dependence, Journal Year: 2022, Volume and Issue: 238, P. 109582 - 109582

Published: July 21, 2022

Language: Английский

Citations

46
Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990–2019: Results from the Disease Burden Study 2019 DOI Creative Commons
Heng Shao, Heyue Du, Quan Gan

et al.

International Journal of Mental Health and Addiction, Journal Year: 2023, Volume and Issue: 22(4), P. 2485 - 2507

Published: Feb. 10, 2023

Abstract Cannabis is the fourth psychoactive substance to be legalized which are of far-reaching significance world. We analyzed data from 2019 Global Burden Disease Study (GBD) estimate incidence and prevalence cannabis use disorder (CUD) calculated disease burden CUD in 204 countries territories 21 regions over past three decades. reported due terms disability-adjusted life years (DALYs), age-standardized rate (ASR), estimated annual percentage change (EAPC), associations between sociodemographic index (SDI) quintiles. Globally, number cases was increasing by 32.3% 1990 males nearly double higher than that female. DALYs increase 38.6% 1990. Young people aged 20–24 old with have highest 2019, followed those younger 20 old. India, Canada, USA, Qatar, Kenya, high SDI quintile areas showed a disease. Nearly 200 million individuals users worldwide, notable condition GBD. The global cultivation cannabis, rooted different cultures, diversified access legalization controversy, promotion medical many other factors promote industry constantly updated upgraded. It deserves more discussion future pathophysiological mechanisms, socioeconomics, law, policy improvement.

Language: Английский

Citations

33
Cannabis Use Disorder and Perioperative Complications DOI
Paul Potnuru,

Srikar Jonna,

George W. Williams

et al.

JAMA Surgery, Journal Year: 2023, Volume and Issue: 158(9), P. 935 - 935

Published: July 5, 2023

Cannabis use is growing in the US and increasingly perceived as harmless. However, perioperative impact of cannabis remains uncertain.

Language: Английский

Citations

28
Cannabis Use and Head and Neck Cancer DOI
Tyler J. Gallagher, Ryan S. Chung, Matthew E. Lin

et al.

JAMA Otolaryngology–Head & Neck Surgery, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 8, 2024

Cannabis is the most commonly used illicit substance worldwide. Whether cannabis use associated with head and neck cancer (HNC) unclear.

Language: Английский

Citations

16
The prevalence of cannabis use disorders in people who use medicinal cannabis: A systematic review and meta-analysis DOI Creative Commons
Danielle Dawson, Daniel Stjepanović, Valentina Lorenzetti

et al.

Drug and Alcohol Dependence, Journal Year: 2024, Volume and Issue: 257, P. 111263 - 111263

Published: March 8, 2024

The prevalence of cannabis use disorders (CUDs) in people who recreationally has been estimated at 22%, yet there is a dearth literature exploring CUDs among medicinal cannabis. We aimed to systematically review the In our systematic and meta-analysis, we followed PRISMA guidelines searched three databases (PsychInfo, Embase PubMed) identify studies examining Metaanalyses were calculated on CUDs. Prevalence estimates pooled across different periods (recent 6-12 months) using DSM-IV DSM-5. conducted 14 eligible publications, assessing with diagnostic criteria, providing data for 3681 participants from five countries. demonstrated that demographic factors, mental health problems management chronic pain associated an elevated risk A meta-analyses was For individuals past months, 29% (95% CI: 21-38%) as per DSM-5 criteria. Similar observed (24%, 14-38%) same period. substantial comparable recreational reasons, emphasizing need ongoing research monitor

Language: Английский

Citations

15
Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials DOI Creative Commons
Haron M. Jeddi, Jason W. Busse, Behnam Sadeghirad

et al.

BMJ Open, Journal Year: 2024, Volume and Issue: 14(1), P. e068182 - e068182

Published: Jan. 1, 2024

The objective of this study is to evaluate the comparative benefits and harms opioids cannabis for medical use chronic non-cancer pain.

Language: Английский

Citations

14
Global epidemiology of cannabis use disorders and its trend from 1990 to 2019: Benchmarking analysis of the global burden of disease study DOI Creative Commons
Kinjal J. Shah,

Umm E. Farwa,

Ankitha Vanaparti

et al.

Journal of Family Medicine and Primary Care, Journal Year: 2024, Volume and Issue: 13(3), P. 881 - 889

Published: March 1, 2024

A BSTRACT Introduction: Cannabis is one of the most widely used psychoactive substances globally, with an increasing trend in its legalization for both medical and recreational purposes various countries. While cannabis offers potential therapeutic benefits, regular use can lead to development Use Disorders (CUDs). Understanding epidemiology CUDs crucial assessing public health burden associated use. Methods: Epidemiological parameters were assessed using Global Burden Disease (GBD) methodology across different age-groups, years, sexes, locations worldwide from 1990-2019. Results: Globally, sexes combined, prevalent cases increased steadily 17.1 million(95%UI=12.7-22.8million) 1990 23.8-million(95%UI=17.8-30.9 million) 2019. All age-adjusted highest number incidence observed High-Income-North-America(HINA)(121/100,000), followed by Australasia(100/100,000), Oceania(83.97/100,000), Tropical Latin America(69.59/100,000). age-standardized disability-adjusted life years rate(ASDR) higher HINA, Australasia, Western-Europe. In male, all-age counts 1.7 million(95%UI=1.3-2.4million) 2.4 million(95%UI=1.8-3.2 The annual percentage change rate(ASIR) was found East-Asia (22%) Middle-East North-Africa(MENA)(15%). age group 15-24 exhibited CUDs. Conclusion: widespread occurrence on a global scale poses substantial challenge health. impact implementing evidence-based interventions mitigating individual, societal, economic burdens. Continued research, collaboration, knowledge dissemination are essential inform policies, prevention efforts, treatment strategies aimed at addressing global-scale.

Language: Английский

Citations

9
Prevalence of and trends in current cannabis use among US youth and adults, 2013–2022 DOI Creative Commons
Delvon T. Mattingly,

Maggie K. Richardson,

Joy L. Hart

et al.

Drug and Alcohol Dependence Reports, Journal Year: 2024, Volume and Issue: 12, P. 100253 - 100253

Published: June 29, 2024

Cannabis use is increasing due to several factors including the adoption of laws legalizing its across United States (US). We examined changes in current cannabis among US youth and adults by key sociodemographic groups. Using data from 2013–2022 National Survey on Drug Use Health (n=543,195), we estimated prevalence (2013–2019, 2020, 2021–2022) trends (i.e., past 30-day) (aged 12–17) 18+) overall age, gender, race ethnicity, educational attainment, total annual family income. also associated with 2013 2019, 2021 2022. increased 7.59 % 11.48 2013–2019, was 11.54 again 13.13 15.11 2021–2022. Among youth, remained constant 2019 In 2022, highest aged 18–34, male, non-Hispanic multiracial, generally lower SES adults. From 2021–2022, groups such as who were 35–49 (14.25–17.23 %), female (11.21–13.00 Hispanic (10.42–13.50 %). Adults 18–25, some college educated, income had consistently higher odds certain Our findings inform prevention harm reduction efforts aimed at mitigating US.

Language: Английский

Citations

9